Mesenchymal stromal cell therapy in COPD: from bench to bedside

COPD is the most frequent chronic respiratory disease and a leading cause of morbidity and mortality. The major risk factor for COPD development is cigarette smoke, and the most efficient treatment for COPD is smoking cessation. However, even after smoking cessation, inflammation, apoptosis, and oxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Mariana A, Lapa e Silva, José Roberto, Rocco, Patricia RM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652911/
https://www.ncbi.nlm.nih.gov/pubmed/29081655
http://dx.doi.org/10.2147/COPD.S146671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652911/
https://www.ncbi.nlm.nih.gov/pubmed/29081655
http://dx.doi.org/10.2147/COPD.S146671

Ejemplares similares